Cargando…
Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization
Parkinson’s disease is the second most frequent neurodegenerative disease, representing a significant medical and socio-economic problem. Modern medicine still has no answer to the question of why Parkinson’s disease develops and whether it is possible to develop an effective system of prevention. T...
Autores principales: | Trifonova, Oxana P., Maslov, Dmitri L., Balashova, Elena E., Urazgildeeva, Guzel R., Abaimov, Denis A., Fedotova, Ekaterina Yu., Poleschuk, Vsevolod V., Illarioshkin, Sergey N., Lokhov, Petr G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277996/ https://www.ncbi.nlm.nih.gov/pubmed/32466249 http://dx.doi.org/10.3390/diagnostics10050339 |
Ejemplares similares
-
A Metabolomics Approach to Pharmacotherapy Personalization
por: Balashova, Elena E., et al.
Publicado: (2018) -
Evaluation of Dried Blood Spot Sampling for Clinical Metabolomics: Effects of Different Papers and Sample Storage Stability
por: Trifonova, Oxana P., et al.
Publicado: (2019) -
Diagnosis of Parkinson’s Disease by A Metabolomics-Based Laboratory-Developed Test (LDT)
por: Lokhov, Petr G., et al.
Publicado: (2020) -
Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease
por: Lokhov, Petr G., et al.
Publicado: (2020) -
n-Butylamine for Improving the Efficiency of Untargeted Mass Spectrometry Analysis of Plasma Metabolite Composition
por: Maslov, Dmitry L., et al.
Publicado: (2019)